BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Biotech Bay

  Questcor Pharmaceuticals, Inc. (Headquarters) to Present At BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York

  August 3, 2009

   · 

  1 min read
• Drug Development

  Keryx Biopharmaceuticals Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial of KRX-0401 (Perifosine) in the Treatment of Multiple Myeloma

  August 3, 2009

   · 

  4 min read
• Business

  PDL BioPharma, Inc. Elects Barry Selick to Its Board of Directors

  August 3, 2009

   · 

  1 min read
• FDA

  Perrigo Company Announces FDA Approval for Generic Version of NASACORT(R) AQ

  August 3, 2009

   · 

  1 min read
• BioCapital

  Shimadzu Corporation Introduce Polymeric, Single-Use Targets for MALDI Analysis

  August 3, 2009

   · 

  1 min read
• Drug Development

  MDRNA, Inc. Reports Positive In Vivo Data Demonstrating That Its UsiRNAs Are Highly Potent Against Metabolic and Oncology Targets

  August 3, 2009

   · 

  4 min read
• Policy

  XenoPort, Inc. Announces Astellas Pharma Inc.'s Plans to File an NDA for XP13512 in Japan

  August 3, 2009

   · 

  1 min read
• Deals

  Swiss Nycomed to Buy Sanofi-Aventis (France), Zentiva’s Local Portfolio; Acquired Portfolio has Annual Revenues of Approximately $24.33 Million

  August 3, 2009

   · 

  1 min read
• Drug Development

  Repros Therapeutics Inc. Suspends Dosing of Proellex(R) and Provides Update on Financial Status

  August 3, 2009

   · 

  5 min read
• Drug Development

  FDA Lifts Partial Clinical Hold on Epilepsy Drug Says Icagen

  August 3, 2009

   · 

  1 min read